» Articles » PMID: 29456159

CD150 Bone Marrow Tregs Maintain Hematopoietic Stem Cell Quiescence and Immune Privilege Via Adenosine

Overview
Journal Cell Stem Cell
Publisher Cell Press
Specialty Cell Biology
Date 2018 Feb 20
PMID 29456159
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

A crucial player in immune regulation, FoxP3 regulatory T cells (Tregs) are drawing attention for their heterogeneity and noncanonical functions. Here, we describe a Treg subpopulation that controls hematopoietic stem cell (HSC) quiescence and engraftment. These Tregs highly expressed an HSC marker, CD150, and localized within the HSC niche in the bone marrow (BM). Specific reduction of BM Tregs achieved by conditional deletion of CXCR4 in Tregs increased HSC numbers in the BM. Adenosine generated via the CD39 cell surface ectoenzyme on niche Tregs protected HSCs from oxidative stress and maintained HSC quiescence. In transplantation settings, niche Tregs prevented allogeneic (allo-) HSC rejection through adenosine and facilitated allo-HSC engraftment. Furthermore, transfer of niche Tregs promoted allo-HSC engraftment to a much greater extent than transfer of other Tregs. These results identify a unique niche-associated Treg subset and adenosine as regulators of HSC quiescence, abundance, and engraftment, further highlighting their therapeutic utility.

Citing Articles

Continuous map of early hematopoietic stem cell differentiation across human lifetime.

Komic H, Schmachtel T, Simoes C, Kulp M, Yu W, Jolly A Nat Commun. 2025; 16(1):2287.

PMID: 40055319 PMC: 11889232. DOI: 10.1038/s41467-025-57096-y.


Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.

Yang S, Seo J, Choi J, Kim S, Kuk Y, Park K Mol Cancer. 2025; 24(1):47.

PMID: 39953555 PMC: 11829473. DOI: 10.1186/s12943-025-02250-9.


Bone marrow niches orchestrate stem-cell hierarchy and immune tolerance.

Furuhashi K, Kakiuchi M, Ueda R, Oda H, Ummarino S, Ebralidze A Nature. 2025; 638(8049):206-215.

PMID: 39743593 DOI: 10.1038/s41586-024-08352-6.


Osteoimmunology in bone malignancies: a symphony with evil.

Song C, Tong T, Dai B, Zhu Y, Chen E, Zhang M J Natl Cancer Cent. 2024; 4(4):354-368.

PMID: 39735445 PMC: 11674455. DOI: 10.1016/j.jncc.2024.09.001.


Cellular crosstalk in the bone marrow niche.

Huang Z, Iqbal Z, Zhao Z, Liu J, Alabsi A, Shabbir M J Transl Med. 2024; 22(1):1096.

PMID: 39627858 PMC: 11613879. DOI: 10.1186/s12967-024-05900-6.


References
1.
Rudra D, Egawa T, Chong M, Treuting P, Littman D, Rudensky A . Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat Immunol. 2009; 10(11):1170-7. PMC: 2764816. DOI: 10.1038/ni.1795. View

2.
Panduro M, Benoist C, Mathis D . Tissue Tregs. Annu Rev Immunol. 2016; 34:609-33. PMC: 4942112. DOI: 10.1146/annurev-immunol-032712-095948. View

3.
Cao H, Heazlewood S, Williams B, Cardozo D, Nigro J, Oteiza A . The role of CD44 in fetal and adult hematopoietic stem cell regulation. Haematologica. 2015; 101(1):26-37. PMC: 4697889. DOI: 10.3324/haematol.2015.135921. View

4.
Morrison S, Scadden D . The bone marrow niche for haematopoietic stem cells. Nature. 2014; 505(7483):327-34. PMC: 4514480. DOI: 10.1038/nature12984. View

5.
Jones D, Wagers A . No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol. 2007; 9(1):11-21. DOI: 10.1038/nrm2319. View